Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Mometasone in OME
NCT02541760Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Apr 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of montelukast in otitis media with effusion (OME) (3 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Treatment response at 1 month. Started Apr 2014; status: completed.
02
Drugs
montelukast
03
Conditions
otitis media with effusion (OME)
Beyond the preview
Go deeper on NCT02541760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541760.